N. Siafakas (Heraklion, Greece), C. Vogelmeier (Marburg, Germany), B. Brockway (Dunedin, New Zealand), C. Tantucci (Brescia, Italy)
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Y. I. Kim, H. Ban, Y. Kim, J. Yu, B. Lee, S. Yun, Y. Kwon, I. Oh, K. Kim, S. Lim, Y. Kim (Gwangju, Republic Of Korea)
|  |
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
E. Seyhan, S. Sökücü, I. Ömür (Istanbul, Turkey)
| |
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
E. Kochetova (Petrozavodsk, Russian Federation)
| |
Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease
H. Oda, C. Koga, S. Takenaka, T. Kawayama, T. Hoshino (Kurume, Japan)
| |
Comparison of nutritional status in two systemic diseases involving respiratory system
D. Mekal, E. Swietlik, A. Doboszynska (Warsaw, Olsztyn, Poland)
| |
Decline of daily activity in COPD patients with frequent and infrequent exacerbations
A. AlAhmari, A. Patel, B. Kowlessar, A. Mackay, R. Singh, J. Allinson, J. Wedzicha, G. Donaldson (London, United Kingdom)
|  |
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
J. Steer, C. Echeverria, J. Gibson, S. Bourke (North Shields, Newcastle-upon-Tyne, United Kingdom)
| |
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
H. Benabdelghaffar, T. Khmiss, S. Fenniche, O. Neffati, L. Fekih, D. Greb, H. Hassene, H. Smadhi, I. Akrout, D. Belhabib, M. L. Megdiche (Ariana, Tunisia)
| |
Gender differences in hospitalized patients with acute exacerbation of COPD
E. Uzaslan, E. Cetindogan, A. Gorek Dilektasli, F. Coskun, D. Ediger, E. Ege (Bursa, Turkey)
| |
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
T. Pertseva, O. Myronenko, N. Klimenko (Dniepropetrovsk, Ukraine)
| |
Key factors associated with readmission in COPD patients
D. Macfie, C. Norton, Y. Goddard, S. Elkin (London, Bucks, United Kingdom)
| |
Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Baha, Kokturk (Ankara, Turkey)
| |
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
N. Gale, A. Albarrati, I. Munnery, M. Munnery, C. John, S. Dennis (Cardiff, United Kingdom)
| |
Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode
L. Iashyna, Y. Feshchenko, S. Moskalenko, M. Polianska, O. Potochniak, V. Kuts (Kiev, Ukraine)
| |
High COPD assessment test (CAT) score is associated with unscheduled health care utilization
F. W. S. Ko, C. K. W. Lai, T. O. Chan, J. C. N. Ngai, A. H. M. Tung, S. S. S. Ng, D. S. C. H. Hui (Hong Kog, Hong Kong)
| |
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
R. Singh, A. Mackay, A. Patel, B. Kowlessar, D. Garcha, S. Brill, R. Sapsford, L. Donnelly, P. Barnes, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Heart-type fatty acid binding protein (H-FABP) and brain natriuretic peptide-fragment (BNP-fragment) in COPD patients with pneumonia
G. Baimakanova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
The effect of Yu-Ping-Feng capsules and Fu-Fang-Dan-Shen tablets on stable COPD
M. Jie, M. Bing (Chengdu, China)
| |
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE)
T. Pertseva, K. Gashynova, O. Bratus, N. Petrik (Dnipropetrovsk, Ukraine)
| |
Chronic obstructive bronchopulmonary pathology in children with different connective tissue disorders (CTD) phenotypes
Z. Nesterenko, A. Dobrokhotova, S. Zaitseva (Lugansk, Ukraine)
| |